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hippocampal LTP in memory formation. In our previous studies, we found the signiﬁcant
enhancement of CA1 hippocampal long-term potentiation (LTP) induced by high-frequency
stimulation (HFS) in rats with chronic visceral pain. However, it is unclear whether the
NR2B-NMDAs are required for the LTP in chronic visceral pain. In this study, a rat model
with irritable bowel syndrome (IBS) was established by colorectal distention (CRD). The
sensitivity of visceral pain and HFS-induced LTP at SC-CA1 synapses were signiﬁcantly
enhanced in IBS-like rats (po0.05). In addition, hippocampal NR2B protein levels signiﬁ-
cantly increased in IBS-like rats (po0.05). To test whether NR2B-NMDAs are responsible for
the LTP, effects of Ro 25-6981, a selective antagonist of NR2B-NMDAs, on ﬁeld potential in
CA1 region were investigated in vitro. Our results demonstrated that Ro 25-6981 dose-
dependently inhibited the facilitation of CA1 LTP in IBS-like rats. The plausible activation
mechanism of hippocampal NR2B-NMDAs in the LTP enhancement was further explored.
Western blot data indicated that expression of tyrosine phosphorylated NR2B protein in
hippocampus signiﬁcantly enhanced in IBS-like rats. Accordingly, genistein, a speciﬁc
inhibitor of tyrosine kinases, dose-dependently blocked the facilitation of hippocampal LTP
in IBS-like rats. Furthermore, EMG data revealed that intra-hippocampal injection of
Ro 25-6981 dose-dependently attenuated the visceral hypersensitivity. In conclusion,
hippocampal NR2B-NMDAs are responsible for the facilitation of CA1 LTP via tyrosine
phosphorylation, which leads to visceral hypersensitivity.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1
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Fig. 1 – Neonatal CRD resulted in visceral hypersensitivity in
adult rats. (A) A original typical recording of EMG under
40–60 mmHg CRD pressure in control and IBS-like rats.
(B) The statistical chart of the percentage of EMG amplitude
over baseline under 40–60 mmHg CRD in control and IBS-
like rats. n¼6 for each group; npo0.05, vs controls. EMG:
electromyography; CRD: colorectal distension; IBS: irritable
bowel syndrome.
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Irritable bowel syndrome (IBS), characterized by recurrent
abdominal pain and altered bowel habit, is a common
somatoform disorder without apparent organic changes
(Matheis et al., 2007; Li et al., 2012). Although the pathogen-
esis is unknown, it involves intestinal hypersensitivity and
emotional stress (Wesselmann et al., 2009; Li et al., 2012).
Currently, patients with IBS are clinically treated to alleviate
pain with anti-spasmmedications, probiotics, or acupuncture
treatments (Wesselmann et al., 2009; MacPherson et al., 2012;
Chiba et al., 2013). However, clinical treatments for IBS
patients remain unsatisfactory, mainly due to the difﬁculty
in suppressing the repeated visceral pain (Asano et al., 2012).
Previous researches related to chronic visceral pain have
mainly focused on the level of periphery and spinal cord,
whereas few have addressed the role of limbic system in visceral
chronic pain. A growing body of clinical evidence has indicated
that nociceptive pain and its emotional components result in the
development of a “chronic pain memory” (Choi et al., 2007;
Sanchez, 2011; Noel et al., 2012). Nociceptive stimulation can
cause not only pain, but pain memory persisting for many years
(Choi et al., 2007; Noel et al., 2012). In addition, Ji et al. (2003)
proposed that pain and learning memory share striking simila-
rities in synaptic plasticity. Long-term potentiation (LTP), as a
cellular model for synaptic plasticity, is proposed as a funda-
mental mechanism of learning and memory (Bliss and
Collingridge, 1993). Chronic pain, namely pathological learning,
is due to long-term plastic changes taking place in the pain-
processing pathway (Wu and Zhuo, 2009; Li et al., 2010). Our
previous study demonstrated that LTP was enhanced in hippo-
campal CA1 region evoked by high-frequency stimulation (HFS)
in IBS-like rats (Zhu et al., 2012). However, plausible molecular
mechanisms of the enhanced synaptic responses in chronic
visceral pain remain largely unclear.
Subunits composed of N-methyl-D-aspartate receptors
(NMDARs) are heteromeric complexes including the essential
NR1 subunit and some regulatory NR2A-D subunits, and the
amount of NR2 expression is developmentally related
(Monyer et al., 1992; Zhuo, 2009). LTP is induced by the
transient activation of NMDARs, particularly by NR2B sub-
unit, in learning and memory formation (Berberich et al.,
2005; Clayton et al., 2002; Oh-Nishi et al., 2009). It is accepted
that the phosphorylation of NR2B-NMDAs may play a key role
in the modulation of NMDA receptor functions (Rostas et al.,
1996; Xu et al., 2012). Nakazawa et al. (2001) provided an
additional evidence that the phosphorylated NR2B protein
increased in the hippocampus after LTP induction. Nakazawa
et al. (2001) also concluded that the Tyr-1472 of NR2B subunit
is a major phosphorylation site which may modulate hippo-
campal synaptic plasticity. Wu and Zhuo (2009) mentioned
“N-methyl-D-aspartate receptor (NMDAR)-dependent synap-
tic plasticity plays roles not only in physiological functions
such as learning and memory, but also in unwanted patho-
logical conditions such as chronic pain”. However, it is still
unclear whether tyrosine phosphorylated NR2B-NMDARs are
required for hippocampal LTP and visceral hypersensitivity.
In this study, IBS-like animal model was established by color-
ectal distention (CRD) during post-natal days 8–14 according toour previous studies (Luo et al., 2014). Firstly, visceral hypersen-
sitivity was evaluated by recording amplitude of EMG to CRD.
Then, expressions of hippocampal NR2B and its tyrosine phos-
phorylation were analyzed by western blot method. Secondly,
effects of Ro 25-6981, a selective antagonist of NR2B-NMDAs, and
genistein, a speciﬁc inhibitor of tyrosine kinase, on CA1 hippo-
campal LTP were tested by electrophysiological recordings
in vitro. Finally, effects of intra-hippocampal injection of Ro 25-
6981 on visceral hypersensitivity were evaluated in IBS-like rats.2. Results
2.1. Hypersensitivity of visceral pain and facilitation
of hippocampal LTP in IBS-like rats
The sensitivity of visceral pain was assessed by recording
response of EMG to CRD pressure in rats. In IBS-like rats, the
visceral pain sensitivity signiﬁcantly increased from 228.427
19.90% to 440.327132.19% under 40mm Hg CRD and from
295.92723.77 to 757.537119.95% under 60mm Hg CRD (Bon-
ferroni t-test, po0.05, Fig. 1B).
To examine whether hippocampal synaptic plasticity was
facilitated in the condition of chronic visceral pain, the ﬁeld
excitatory postsynaptic potential (fEPSP)s in the hippocampal
CA1 region was recorded. The fEPSPs were recorded 10 min
pre-HFS and 60 min post-HFS in control and IBS-like rats
(Fig. 2A and B). The slope of fEPSPs increased by 99.1710.8%
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IBS-like rats, while 58.476.8% in the controls (Student's t-test,
po0.05, Fig. 2A).The amplitude of fEPSPs increased by
105.1713.0% and 48.6711.5%, respectively, of the baseline
mean control values at 60 min post-HFS in IBS-like rats and
controls (Student's t-test, po0.05, Fig. 2B). The enhancement
lasted for more than 1 h until the end of experiment. These
results suggested that the CA1 hippocampal LTP was facili-
tated in IBS-like rats. These results were consistent with our
previous reports (Zhu et al., 2012).
2.2. Upregulation of hippocampal both NR2B protein
and its phosphorylation in IBS-like rats
Western blot results indicated that expression of hippocampal
NR2B protein signiﬁcantly enhanced by 34% (from 0.8670.09 toFig. 2 – The enhanced LTP in hippocampal CA1 region
evoked by HFS in IBS-like rats. The standardized fEPSPs
slope (A) and (B) amplitude in control and IBS-like rats. LTP
was induced by two trains of HFS (200 pulses at 200 Hz, with
inter-train interval of 10 s). Examples of representative
fEPSPs traces obtained from control and IBS slices at 5 min
pre-HFS and at 60 min post-HFS, respectively. Neonatal CRD
resulted in the facilitation of hippocampal LTP in adult rats.
n¼8 slices from four rats for each group. po0.05, vs controls.
HFS: high frequency stimulation; IBS: irritable bowel
syndrome; fEPSP: ﬁeld excitatory postsynaptic potential.1.1570.09) in IBS-like rats as compared with that in controls
(unpaired t-test, t¼3.737, po0.05, Fig. 3B), implying that the
NR2B protein may be implicated in the facilitation of hippo-
campal LTP in chronic visceral pain. Expression of tyrosine
phosphorylation of hippocampal NR2B protein increased by
80% (from 0.2670.02 to 0.4670.04) in IBS-like rats as compared
with that in controls (unpaired t-test, t¼8.374, po0.05,
Fig. 3B), suggesting that tyrosine phosphorylation may be a
activation mechanism of hippocampal NR2B-NMDAs in chronic
visceral hypersensitivity. Furthermore, the ratio (0.2970.03) of
normalized pho-NR2B of normalized NR2B in IBS-like rats was
signiﬁcantly enhanced as compared with that (0.3970.08) in
controls (unpaired t-test, t¼2.791, po0.05, Fig. 3C).
2.3. The inhibitory effects of Ro 25-6981 on CA1
hippocampal LTP in IBS-like rats in vitro
To examine whether the NR2B-NMDARs were required for the
facilitation of CA1 hippocampal LTP, the effect of Ro 25-6981 on
hippocampal LTP was tested in IBS-like rats. Bath application of
Ro 25-6981 (0.25, 0.5, and 1.0mg/L or 0.67, 1.33, 2.67 μM) into the
brain slices had no signiﬁcant effects on basal synaptic
responses in IBS-like rats (ANOVA, p40.05, Fig. 4A and B). After
HFS, 0.25mg/L (or o.67 μM) Ro 25-6981 had no signiﬁcant inﬂu-
ence on fEPSPs in IBS-like rats (ANOVA/SNK-q-test, p40.05,
Fig. 4). However, 0.5mg/L (or 1.33 μM) Ro 25-6981 reduced the
amplitude and slope of fEPSPs by 59% (from 100.1717.9% to
41.4712.9%) and 38% (from 96.2710.8% to 59.8714.1%), respec-
tively, at 60min post-HFS (ANOVA/SNK-q-test, po0.05, Fig. 4A
and B). 1.0mg/L (or 2.67 μM) Ro 25-6981 inhibited the amplitude
and slope of fEPSPs by 72% (from 100.1717.9% to 28.0710.7%)
and 54% (from 96.2710.8% to 44.3713.4%), respectively, at
60min post-HFS (ANOVA/SNK-q-test, po0.05, Fig. 4A and B).
The suppression of the CA1 hippocampal LTP by Ro 25-6981
presented a dose-dependent manner (ANOVA/SNK-q-test,
po0.05, Fig. 4A and B). These results suggested that NR2B-
NMDAs played an essential role in the enhancement of LTP in
hippocampal CA1 region of IBS-like rats.
2.4. Tyrosine kinase inhibitor suppressed the facilitation
of CA1 hippocampal LTP in IBS-like rats in vitro
The expression of hippocampal tyrosine phosphorylation of
NR2B protein signiﬁcantly increased in IBS-like rats as com-
pared with that in controls (unpaired t-test, po0.05, Fig. 3B).
To further explore the potential activation mechanism of
NR2B-NMDAs in enhancement of hippocampal LTP, the
effects of genistein, a speciﬁc inhibitor of tyrosine kinases,
on the induction and maintenance of LTP were estimated in
IBS-like rats. Before HFS, bath application of genistein (2.5, 5,
and 10 mg/L or 9.25, 18.5, 37 μM) had no signiﬁcant effects on
basic fEPSPs in IBS-like rats (ANOVA, p40.05, Fig. 5A and B).
After HFS, 2.5 mg/L (or 9.25 μM) genistein had no signiﬁcant
inﬂuence on the fEPSPs in IBS-like rats (ANOVA/SNK-q-test,
p40.05, Fig. 5A and B). However, 5 mg/L (or 18.5 μM) genistein
could signiﬁcantly inhibit the amplitude of fEPSPs by 41%
(from 100.1717.9% to 59.5716.9%), and the slope of fEPSPs by
31% (from 96.2710.8% to 66.1721.7%) at 60 min post-HFS in
IBS-like rats (ANOVA/SNK-q-test, po0.05, Fig. 5A and B).
Moreover, 10 mg/L (or 37 μM) genistein could signiﬁcantly
Fig. 3 – Expression of hippocampal NR2B-containing NMDA receptors in rats. (A) Western blot results showed that the protein
expression of hippocampal NR2B-NMDAs and tyrosine phosphorylation of NR2B-NMDAs in rats. (B) Statistical chart showed that
expression of NR2B-NMDAs and tyrosine phosphorylation of NR2B-NMDAs signiﬁcantly increased in the IBS-like rats, n¼3, for each
group. (C) The ratio of normalized pho-NR2B of normalized NR2B in hippocampus of rats. The ratio was enhanced in IBS-like rats.
npo0.05, vs controls. NR2B: N-methyl-D-aspartic acid receptor 2B subunit; IBS: irritable bowel syndrome.
Fig. 4 – Inhibitory effects of Ro 25-6981 on enhanced LTP at SC-CA1 synapses in IBS-like rats. The effect of Ro 25-6981 on the
standardized fEPSPs amplitude (A) and slope (B) in IBS-like rats. Bath application of Ro 25-6981 (0.5-1.0 mg/L or 1.33- 2.67 μM)
dose-dependently blocked the LTP in IBS-like rats. LTP was induced by two trains of HFS (200 pulses at 200 Hz, with inter-
train interval of 10 s). N¼8 slices from four rats for each group. npo0.05, vs IBSþDMSO rats. Ro: Ro 25-6981; L: low dosage
(0.25 mg/L or 0.67 μM); M: medial dosage (0.5 mg/L or 1.33 μM); H: high dosage (1.0 mg/L or 2.67 μM); IBS: irritable bowel
syndrome; HFS: high frequency stimulation; LTP: long-term potentiation; fEPSP: ﬁeld excitatory postsynaptic potential.
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28.4710.2%), and the slope by 70% (from 96.2710.8% to
28.9712.0%) at 60 min post-HFS in IBS-like rats (ANOVA/
SNK-q-test, po0.05, Fig. 5A and B). These results suggested
that tyrosine phosphorylation of CA1 hippocampal NR2B-
NMDAs was involved in the facilitation of hippocampal LTP
in IBS-like rats.To further examine the correlation of tyrosine kinase activity
with the maintenance of hippocampal LTP in IBS-like rats,
genistein was applied at 15 min post-LTP induction. After LTP
induction, 2.5 mg/L (or 9.25 μM) genistein had no signiﬁcant
inﬂuence on the fEPSPs in IBS-like rats (ANOVA/SNK-q-test,
p40.05, Fig. 6A and B). However, 5 mg/L (or 18.5 μM) genistein
could signiﬁcantly inhibit the slope of fEPSPs by 31% (from
Fig. 5 – Suppression effects of genistein on enhanced LTP in IBS-like rats. The effect of genistein on the standardized fEPSPs
amplitude (A) and slope (B) in IBS-like rats. Genistein (5–10 mg/L or 18.5–37 μM) dose-dependently blocked the LTP in IBS-like
rats. LTP was induced by two trains of HFS (200 pulses at 200 Hz, with inter-train interval of 10 s). N¼8 slices from four rats for
each group.npo0.05, vs IBSþDMSO rats. G: genistein; L: low dosage (2.5 mg/L or 9.25 μM); M: medial dosage (5 mg/L or 18.5 μM);
H: high dosage (10 mg/L or 37 μM); IBS: irritable bowel syndrome; HFS: high frequency stimulation; LTP: long-term
potentiation; fEPSP: ﬁeld excitatory postsynaptic potential.
Fig. 6 – Tyrosine phosphorylation of the NR2B subunit contributes to the maintenance of LTP. Effects of genistein on the
fEPSPs amplitude (A) and slope (B) in IBS-like rats. Genistein (5–10 mg/L or 18.5–37 μM) dose-dependently blocked the
maintenance of LTP 30 min and 60 min post-HFS in IBS-like rats. LTP was induced by two trains of HFS (200 pulses at 200 Hz,
with inter-train interval of 10 s). N¼6 slices from three rats for each group. npo0.05, vs IBSþDMSO rats. G: genistein; L: low
dosage (2.5 mg/L or 9.25 μM); M: medial dosage (5 mg/L or 18.5 μM); H: high dosage (10 mg/L or 37 μM); IBS: irritable bowel
syndrome; HFS: high frequency stimulation; LTP: long-term potentiation; fEPSP: ﬁeld excitatory postsynaptic
b r a i n r e s e a r c h 1 5 7 0 ( 2 0 1 4 ) 4 3 – 5 3 47105.6778.37% to 72.9074.02%) and the amplitude of fEPSPs by
47% (from 144.46711.79% to 76.0177.77%), slope of fEPSPs by
44% (from 119.8879.70% to 67.60710.65%) and the amplitude of
fEPSPs by 47% (from 148.83713.67% to 79.5077.62%), respec-
tively, at 30 and 60min post-HFS in IBS-like rats (ANOVA/SNK-
q-test, po0.05, Fig. 6A and B). Moreover, 10 mg/L (or 37 μM)
genistein could signiﬁcantly block the slope of fEPSPs by 64%
(from 105.6778.37% to 38.2374.88%) and the amplitude of
fEPSPs by 68% (from 144.46711.79% to 46.85714.30%), slope
of fEPSPs by 71% (from 119.8879.70% to 34.9674.94%) and
the amplitude of fEPSPs by 65% (from 148.83713.67% to
51.61717.17%), respectively, at 30 and 60min post-HFS in
IBS-like rats (ANOVA/SNK-q-test, po0.05, Fig. 6A and B). The
results showed that genistein signiﬁcantly inhibited CA1 hip-
pocampal LTP at 30 min after LTP induction in IBS-like rats,
and the inhibitory effect sustained for at least 60min. These
results provide new evidence to demonstrate that tyrosine
phosphorylation of CA1 hippocampal NR2B-NMDAs was
involved in the maintenance of hippocampal LTP in IBS-
like rats.2.5. Ro 25-6981 treatment attenuated visceral
hypersensitivity in IBS-like rats
Whether NR2B-dependent facilitation of hippocampal LTP was
involved in visceral hypersensitivity was studied in IBS-like
rats. Effects of NR2B-NMDAs on visceral hypersensitivity were
examined in vivo. Bilateral intra-hippocampal injection of Ro
25-6981 (1, 2, 4 μg/μl, 2 μl each side) had no effect on the
response of EMG to 40–60mmHg CRD in controls (Bonferroni
t-test, p40.05, Fig. 7A and C). There was no obvious change in
responses of EMG to 40–60mmHg CRD between 1 μg/μl Ro
25-6981 and vehicle in IBS-like rats (Bonferroni t-test, p40.05,
Fig. 7B and D). Responses of EMG to 40–60mmHg CRD were
decreased by 39% (from 413.89723.29% to 253.44726.17%) and
35% (from 593751.64% to 382.60723.17%), respectively, after
injection of 2 μg/μl Ro 25-6981 as compared with vehicle in IBS-
like rats (Bonferroni t-test, po0.05, Fig. 7B and D). Responses of
EMG were decreased by 75% (from 554.25765.38% to
141.16710.10%) under 40mmHg CRD, and decreased by 61%
(from 704.567139.73% to 278.27739.76%) under 60mmHg CRD
Fig. 7 – Bilateral intra-hippocampal injection of Ro 25-6981 decreased chronic visceral pain in IBS-like rats. The percentage of
EMG amplitude over baseline under 40 (A) and 60 mmHg CRD (C) at 30 min after injection in controls; under 40 (B) and
60 mmHg CRD (D) at 30 min after injection in IBS-like rats. Bilateral intra-hippocampal injection of Ro 25-6981 (2–4 μg/μl, 2 μl
per side) signiﬁcantly inhibited chronic visceral pain in IBS-like rats. The time course of EMG were under 40 (E) and 60 mmHg
CRD (F) in IBS-like rats. The maximal inhibition was observed at 30 min after Ro 25-6981 administrated in IBS-like rats (n¼6
for each group); npo0.05. vs before the injection of Ro 25-6981; EMG: electromyography; CRD: colorectal distension; IBS:
irritable bowel syndrome; Ro: Ro 25-6981.
b r a i n r e s e a r c h 1 5 7 0 ( 2 0 1 4 ) 4 3 – 5 348after injection of 4 μg/μl Ro 25-6981 as compared with vehicle in
IBS-like rats (Bonferroni t-test, po0.05, Fig. 7B and D).
Responses of EMG were signiﬁcantly decreased by 30%
(from 360.88731.30% to 253.44726.17%) under 40 mmHg CRD
after injection of 2 μg/μl Ro 25-6981 as compared with 1 μg/μl
Ro 25-6981 in IBS-like rats, and signiﬁcantly decreased by 28%
(from 502.54733.87% to 382.60723.17%) under 60 mmHg CRD
(Bonferroni t-test, po0.05, Fig. 7B and D). Responses of EMG
were signiﬁcantly decreased by 61% (from 360.88731.30% to
141.16710.10%) under 40 mmHg CRD after injection of 4 μg/μl
Ro 25-6981 as compared with 1 μg/μl Ro 25-6981 in IBS-like
rats, and signiﬁcantly decreased by 45% (from 502.54733.86%
to 278.27739.76%) under 60 mmHg CRD (Bonferroni t-test,po0.05, Fig. 7B and D). These EMG data showed that intra-
hippocampal injection of the NR2B-NMDAs antagonist had a
dose-dependent inhibitory effect on visceral hypersensitivity
in IBS-like rats.
These results suggested that NR2B-NMDAs-dependent
facilitation of hippocampal LTP may a key mechanism under-
lying the visceral hypersensitivity.
2.6. Time course of inhibitory effect of Ro 25-6981
on visceral hypersensitivity in IBS-like rats
To further observe time proﬁles of Ro 25-6981, responses of
EMG to 40–60mmHg CRD were recorded every half an hour
b r a i n r e s e a r c h 1 5 7 0 ( 2 0 1 4 ) 4 3 – 5 3 49within three hours after intra-hippocampal injection of 4 μg/μl
Ro 25-6981 in IBS-like rats. The lowest percentage of EMG
amplitude over baseline was observed at 30min after injection
of 4 μg/μl Ro 25-6981 (141.16710.10% under 40mmHg CRD;
278.27739.76% under 60mmHg CRD). Responses of EMG to
40mmHg CRD were lowered by 69%, 52%, 37%, and 32%
respectively at 30, 60, 90, and 120 min after injection of
4 μg/μl Ro 25-6981 in IBS-like rats. Responses of EMG to
60mmHg CRD were lowered by 65%, 60%, 52%, 45% and 33%
respectively at 30, 60, 90, and 120 min after injection of 4 μg/μl
Ro 25-6981 in IBS-like rats. These results suggested that the
maximal inhibition was observed at 30min after administra-
tion of Ro 25-6981 under either 40 or 60 mmHg CRD in IBS-like
rats (Bonferroni t-test, po0.05, Fig. 7E and F).3. Discussion
We previously observed that LTP induced by HFS at SC-CA1
synapses signiﬁcantly increased in IBS-like rats (Zhu et al.,
2012). In the present study, we provide further evidence to
demonstrate that hippocampal NR2B receptor plays an
important role in the enhanced LTP and visceral hypersensi-
tivity in IBS-like rats and that activities of NR2B-NMDARs are
mainly regulated by tyrosine kinase. Firstly, expressions of
the hippocampal NR2B protein and tyrosine phosphorylated
NR2B protein signiﬁcantly increased in IBS-like rats. Sec-
ondly, the application of Ro 25-6981could dose-dependently
block the facilitation of LTP in hippocampal CA1 region.
Thirdly, genistein could also dose-dependently inhibit the
induction and maintenance of hippocampal LTP in IBS-like
rats in vitro. Finally, bilateral intra-hippocampal injection of
Ro 25-6981 signiﬁcantly attenuated visceral hypersensitivity
in IBS-like rats.
3.1. Facilitation of hippocampal LTP in IBS-like rats
It is claimed that synaptic plasticity is a key mechanism for
chronic pain and plastic changes contributes to pain percep-
tion, fear and memory in Science (Li et al., 2010). It is
concluded that LTP is a well-characterized form of synaptic
plasticity (Ji et al., 2003; Wu and Zhuo, 2009; Li et al., 2010). In
this study, the amplitude and slope of fEPSPs were ca. 49%
and 57%, respectively, in controls, which is in agreement with
data reported by Li et al. (2011). Although there are differ-
ences between the synaptic plasticity contributing to learning
memory and pain memory, there are also striking similarities
(Ji et al., 2003). In addition, LTP induced by HFS in the
hippocampal CA1 region signiﬁcantly enhanced and main-
tained for more than 1 h in IBS-like rats. These results
indicate that CRD in neonatal rats could result in chronic
visceral pain-related memory when they grew up. Thus, LTP
is a key mechanism of chronic visceral pain in agreement
with memory and other pains (Kodama et al., 2007; Li et al.,
2010; Ohnami et al., 2012).
Our results demonstrated that LTP induced by HFS at SC-
CA1 synapses signiﬁcantly enhanced in IBS-like rats. This
viewpoint is conﬂict with that in neuropathic pain reported
by Kodama et al. (2007). They reported that hippocampal
synaptic transmission in CA1 region was impaired in amurine model of neuropathic pain prepared by partial liga-
tion of the sciatic nerve. Some reasonable explanations will
be needed. Firstly, types of stimulus inducing LTP in neuro-
pathic and visceral pain are different. Their LTP was induced
by tetanus in the neuropathic pain, while ours was induced
by HFS at SC-CA1 synapses. Secondly, there are some funda-
mental differences between the mechanisms responsible in
visceral and somatic pain (Wesselmann et al., 2009). The
neuropathic pain model reported by Kodama et al. is one of
somatic pain. Thus, differences of pain models may result in
the variation in synaptic responses. Finally, the model
reported by Kodama et al. was prepared by partial ligation
of the sciatic nerve, which is an acute pain, while the visceral
pain established in this study is a chronic pain (up to 8
weeks). However, the interpretation of mechanisms respon-
sible to different pains will need further studies in the future.
Compared to other limbic structures such as the anterior
cingulate cortex and amygdala, the role of the hippocampus
in the formation of chronic pain is not fully elucidated
(Zhuo, 2007; Li et al., 2010; Kim et al., 2010; Crock et al.,
2012). Our results reveal that hippocampal formation plays an
important role in chronic visceral pain. There are several
observations to support our results. Firstly, pain is a complex
phenomenon resulting from a three-dimensional integra-
tion of sensory-discriminative, affective-motivational and
cognitive-evaluative axes (Liu and Chen, 2009). Pain memory
may persist for many years, which may be a key role for
chronicity and repeatability of IBS (Choi et al., 2007; Noel
et al., 2012). Secondly, hippocampal synaptic plasticity is a
main cellular model for memory (Bliss and Collingridge,
1993), which contributes to the formation of pain-related
memory and emotional responses (Chou et al., 2011). Thirdly,
CA1 hippocampal synaptic transmission could be inﬂuenced
by neuropathic and inﬂammatory pain (Kodama et al., 2007;
Zhao et al., 2009). Furthermore, recent studies have demon-
strated that CA1 plays a critical role in the learning and
memory (Porte et al., 2011; Place et al., 2012). Khanna and
Sinclair proposed that noxious stimuli produce prolonged
changes in the CA1 region (Khanna and Sinclair, 1989).
Finally, induction of persistent peripheral neuropathic pain
could affect basic hippocampal processing such as the spatial
encoding performed by CA1 region cells (Cardoso-Cruz et al.,
2011). Thus, hippocampal formation plays an integral role in
chronic visceral pain.
3.2. Role of NR2B in facilitation of CA1 hippocampal LTP
and formation of visceral hypersensitivity in IBS-like rats
Subunits composed of NMDA receptors are classiﬁed as
families of NR1, NR2, and NR3 based on genotype (Monyer
et al., 1992). As mentioned, NR2 subunit is composed of
NR2A-D, which has a strong effect on the biophysical and
pharmacological properties of NMDAR assemblies (Monyer
et al., 1992; Zhuo, 2009). NR2B-NMDAs are widespread in
areas related to pain transmission, such as the dorsal horn of
spine and hippocampus (Oh-Nishi et al., 2009; Luo et al.,
2014). Some experiment in mutant mice suggested that LTP is
dependent on the NR2A subunit important for LTP (Clayton
et al., 2002; Oh-Nishi et al., 2009; Zhuo, 2009). Ro 25-6981 is
5000 folds more selective for the heteromeric NR1/NR2B
b r a i n r e s e a r c h 1 5 7 0 ( 2 0 1 4 ) 4 3 – 5 350receptors than the NR1/NR2A receptors (Fischer et al., 1997).
In our study, expression of hippocampal NR2B protein
increased in IBS-like rats, which was similar with the
formalin-induced chronic pain (Wei et al., 2001). Together
with, Ro 25-6981, a selective antagonist of NR2B-NMDAs,
dose-dependently inhibited the facilitation of hippocampal
LTP in vitro in IBS-like rats. Thus, it is hypothesized that
NR2B subunit plays a critical role in hippocampal LTP
enhancement in chronic visceral pain, which is in consistent
with the study of genetic overexpression of NR2B subunit
indicating the involvement of NR2B receptor in LTP (Tang
et al., 1999).
A study in vivo indicated intra-hippocampal injection of
nonselective NMDA antagonists, AP5 and MK801, signiﬁcantly
reduced pain behavior in both the acute and tonic phases of
the formalin test (Chen et al., 2009). However, the therapeutic
potential of NMDA antagonists has been restricted in the
treatment of chronic pain due to their serious side effects
including hallucinations, learning and memory impairments,
and sensorimotor disturbances (Soleimannejad et al., 2007; Qu
et al., 2009). Our present study indicated that the blockade of
NR2B receptors in the hippocampal CA1 region signiﬁcantly
inhibited neonatal CRD – induced chronic visceral hypersensi-
tivity without signiﬁcant side effects. In our studies, Ro 25-6981
attenuated visceral pain by ca. 45% and 70%, respectively,
30 min after intrathecal (75 μg/10 μl) and intra-hippocampal
(4 μg/2 μl) injection (Luo et al., 2014). Explanations for the
ﬁndings are that hippocampal NR2B subunit may play much
more important role in chronic visceral pain.
In other studies, the application dosage of Ro 25-6981 was
0.3–2 mg/L (Bartlett et al., 2007; Li and Han, 2008), and in this
study, the effective dosages of Ro 25-6981 were between 0.5
and 1.0 mg/L. In our study, intra-hippocampal injection of Ro
25-6981 did not completely attenuate visceral pain hypersen-
sitivity. The reason is likely because of other signaling
molecule in hippocampus formation and other brain regions
mediating chronic pain (Zhuo, 2007; Crock et al., 2012; Ikeda
et al., 2013). Therefore, further studies will be required to the
comprehensive understanding of mechanisms of chronic
visceral pain.
3.3. Contribution of tyrosine phosphorylated NR2B-
NMDAs to CA1 hippocampal LTP in IBS-like rats
The phosphorylation of NR2B-NMDAs plays a key role in
modulation of NMDA receptor functions (Rostas et al., 1996;
Nakazawa et al., 2001; Xu et al., 2012). The intracellular
C-terminal cytoplasmic region of the NR2B-NMDAs is a func-
tionally important region targeted by numerous protein kinases,
including Fyn-mediated tyrosine kinases (Nakazawa et al., 2001).
NR2B-NMDAs have seven phosphorylation sites for tyrosine
kinase, with its main phosphorylation sites including S1303,
S1323, S1480, Y1252, Y1336, and Y1472 (Nakazawa et al., 2001;
Qiu et al., 2011). It is addressed that Tyr-1472 of NR2B is a major
phosphorylation site, which may modulate hippocampal synap-
tic plasticity (Nakazawa et al., 2001). In this study, western blot
data showed that expression of Tyr-1472 of NR2B protein in
hippocampus signiﬁcantly enhanced in IBS-like rats, in agree-
ment with the paper reported by Xu et al. in inﬂammatory pain
(Xu et al., 2012). We reasonably infer that hippocampal NR2Bphosphorylation at tyrosine 1472 may contribute to central
sensitization of chronic visceral pain.
Since the tyrosine phosphorylation of NR2B subunit has
already increased in IBS-like rats, these results do not exclude
the possibility that there may be the constitutive activity of
tyrosine kinase in maintaining the level of phosphorylation.
As mentioned, the level of the phosphorylated NR2B protein
increased in the hippocampus after induction of LTP (Rostas
et al., 1996). In addition, tyrosine phosphorylation of the
NMDA receptor contributes to the maintenance of LTP. Our
results suggested that tyrosine phosphorylation of the NR2B
subunit contributed to the maintenance of LTP in IBS-like
rats, which is similar with the ﬁndings reported by Rostas
et al. (1996). Thus, tyrosine phosphorylation activity was
enhanced in the maintenance of CA1 hippocampal LTP in
IBS-like rats. Rostas et al. (1996) mentioned “the increase in
tyrosine phosphorylation of NR2B required LTP induction but
was not involved in the induction process itself since the
increase in tyrosine phosphorylation was not observed until
between 5 and 15 min after LTP induction”. In this study, the
tyrosine kinase inhibitor restrains the induction of LTP,
which inhibits the tyrosine phosphorylation of NR2B and
results in the inhibitory effect on LTP maintenance.
Thus, it is speculated that tyrosine phosphorylation is one
of the activating mechanisms of the hippocampal NR2B-
NMDAs in the facilitation of LTP in IBS-like rats.4. Experimental procedures
4.1. Animals
Male Sprague-Dawley neonatal rats were provided by the
Department of Experimental Animal Center, Fujian Medical
University. The animals were housed with a nursing adult
female rat until they were 25 days old. After separation from
the adult female rats, the weaned rats were raised for two
months before surgery and housed six in a cage with access
to food and water ad libitum. The animal experimental
procedures were conducted in accordance with the guidelines
of the International Association for the Study of Pain
(Zimmermann, 1983). The experiments were approved by
the Animal Care and Use Committee of Fujian Medical
University.
4.2. Animal model of visceral hypersensitivity
In order to study mechanisms of chronic visceral pain, we
developed a modiﬁed rat model of IBS as described by
Al-Chaer et al., (2000). Hypersensitive SD rats were daily
generated by 60 mmHg CRD during postnatal days 8–14. The
controls received the same procedure except CRD. Above
experiments were done by the same investigator. No treat-
ment, procedures or further interventions were performed by
the investigator until the testing date (8 weeks old).
4.3. Assessment of visceral hyperalgesia
Visceral hypersensitivity was assessed by electromyographic
(EMG) measurements of visceromoter response to CRD as
b r a i n r e s e a r c h 1 5 7 0 ( 2 0 1 4 ) 4 3 – 5 3 51described previously (Luo et al., 2014). Brieﬂy, under anesthe-
sia with isoﬂuorane by anesthesia machine (VMR, Matrix,
USA), two silver bipolar electrodes were inserted the external
oblique muscle of the abdomen. After the balloon was
advanced into the colon, it was secured by taping the
attached tubing to the rat's tail. The balloon was inﬂated to
40 and 60 mmHg for 10 s followed by 4 min rest. Responses of
EMG were recorded three times under the same CRD pressure
in each rat. The average of three recordings is taken as the
magnitude of EMG activity. The magnitude of EMG activity
was measured by a RM6240BD multi-channel physiological
signal acquisition and processing system (the instrument,
made in Chendu, China). The EMG data of 10 s before CRD
(baseline) and 10 s during CRD were recorded for calculation.
The responses were taken as the percentage of EMG ampli-
tude during CRD over baseline using RM6420BD program.
In order to avoid the interference of other factors, a single blind
operation was adopted in the experiment. Furthermore, the rats
were kept in a quiet environment, with relative humidity
maintained at 40–70% and room temperature at 23–27 1C.
4.4. Surgery and intra-hippocampal injection
The rats were anesthetized by intraperitoneal chloral hydrate
(300 mg/kg) and were placed on a stereotaxic instrument
(Narishige, Japan). The skin was cut along the midline of the
skull. A cotton swab soaked with 3% H2O2 was used to abrade
the tissue until the skull was exposed. A stainless steel guide
cannula of 0.65 mm outer-diameter was placed stereotaxically
and directed into the CA1 region of the hippocampus (4.0 mm
posterior to the bregma, 2.8 mm lateral to the midline and
2.5mm from the surface of the skull) according to Paxinos and
Watson (1998). The two cannulas were ﬁxed on the skull with
two small screws by dental resin. The rats were given 3 days to
recover from the operation. On the day of experiment, a
stainless steel injection tube with 0.4 mm diameter was directly
inserted into the guide cannula with 0.5 mm beyond the tip of
the latter. Then 2 μl of drug solution was injected into the CA1
region of the hippocampus within 5min. Control group was
injected with the vehicle. The injection needle was left in place
for an additional 5 min to allow diffusion.
4.5. Hippocampal slice preparation
Rats were anesthetized with intraperitoneal chloral hydrate
(300 mg/kg), and immediately after decapitation the brains
were placed in ice-cold ACSF bubbled with 95% O2–5% CO2 (pH
7.4). The hippocampal formation was cut into 500-μm-thick
transverse slices using a vibratome (ZQP-86, Zhixing Com-
pany, Shanghai, China) after ﬁxed using 502 glue. The slices
were incubated in an interface recording chamber main-
tained at a constant temperature (2871 1C), and were allowed
to equilibrate for at least 1 h. The upper surface of the slices
was in contact with a humidiﬁed, oxygenated (95% O2–5%
CO2) stream.
4.6. Electrophysiological recordings
The Schaffer collateral-Commissural pathway was stimu-
lated and fEPSPs recorded from the dendritic layer of theCA1 pyramidal cells as reported by Kleppisch et al. (1999). The
amplitude of the fEPSPs was measured for the downward
peak. The intensity of the test stimulus, delivered at 0.1 Hz,
was adjusted for each slice so that the fEPSPs were equal to
approximately 50% of the maximal amplitude of the fEPSPs.
The slices were stimulated for 10 min (0.01 Hz) so as to
generate baseline values before LTP induction. Baseline
values were recorded for at least 10 min before application
of drugs. LTP was induced by two trains of HFS (200 pulses at
200 Hz, with inter-train interval of 10 s). fEPSPs were ampli-
ﬁed and analyzed using a RM6240BD multi-channel physio-
logical signal acquisition and processing system.
4.7. Western blotting
Equal amounts of protein (50 μg) from the hippocampus of rats
were separated and electro-transferred onto PVDF membranes
(Invitrogen, USA), which were probed with mouse anti-NR2B
monoclonal antibody (1:500, Abcam, USA), Rabbit anti-NR2B
(pTyr1472) polyclonal antibody (1:1000, Abcam, USA) and
mouse anti-β-actin primary antibody (1:1000, Abcam, USA).
Blots were washed and incubated in peroxidase-conjugated
goat anti-rabbit Ig G (1:5000, Abcam, USA) or goat anti-mouse
Ig G (1:5000, Abcam, USA). Bands were visualized using an ECL
system (Made in Xiamen, China).
4.8. Statistical analysis
All data were expressed as mean7S.E.M. A one-way repeated
measures analysis of variance (ANOVA) was used to determine
whether there was a signiﬁcant difference in the response to
CRD pressure between control and IBS-like rats. One or two way
repeated measures analysis of variance (ANOVA) followed by
Bonferroni post-hoc test was used for multiple comparison
after intra-hippocampal injection of compounds. Western blot
results were examined by unpaired t-test. LTP was measured
60min after HFS and reported as mean7SEM of baseline fEPSPs
amplitude or slope. Student's t-test was used to compare the
hippocampal ﬁeld potential in control and IBS-like rats. One
way ANOVA with Student–Newman–Keuls (SNK) multiple
comparisons post-hoc analysis was used to compare the
different groups of hippocampal slices of rats in vitro (SPSS
10.0). po0.05 was considered to be statistically signiﬁcant.Conﬂict of interest statement
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